232 related articles for article (PubMed ID: 24931195)
1. Constitutive activity in melanocortin-4 receptor: biased signaling of inverse agonists.
Tao YX
Adv Pharmacol; 2014; 70():135-54. PubMed ID: 24931195
[TBL] [Abstract][Full Text] [Related]
2. Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors.
Mo XL; Tao YX
Biochim Biophys Acta; 2013 Dec; 1832(12):1939-48. PubMed ID: 23791567
[TBL] [Abstract][Full Text] [Related]
3. Biased signaling initiated by agouti-related peptide through human melanocortin-3 and -4 receptors.
Yang Z; Tao YX
Biochim Biophys Acta; 2016 Sep; 1862(9):1485-94. PubMed ID: 27208795
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic functions of the transmembrane domain 6 of human melanocortin-4 receptor.
Huang H; Tao YX
J Mol Endocrinol; 2012 Dec; 49(3):237-48. PubMed ID: 23014839
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans.
Srinivasan S; Lubrano-Berthelier C; Govaerts C; Picard F; Santiago P; Conklin BR; Vaisse C
J Clin Invest; 2004 Oct; 114(8):1158-64. PubMed ID: 15489963
[TBL] [Abstract][Full Text] [Related]
6. Defect in MAPK signaling as a cause for monogenic obesity caused by inactivating mutations in the melanocortin-4 receptor gene.
He S; Tao YX
Int J Biol Sci; 2014; 10(10):1128-37. PubMed ID: 25332687
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase inhibitor-dependent inverse agonism of agouti-related protein on melanocortin 4 receptor in sea bass (Dicentrarchus labrax).
Sánchez E; Rubio VC; Thompson D; Metz J; Flik G; Millhauser GL; Cerdá-Reverter JM
Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1293-306. PubMed ID: 19225141
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of melanocortin-4 receptor for AGRP inverse agonism.
Chen M; Celik A; Georgeson KE; Harmon CM; Yang Y
Regul Pept; 2006 Sep; 136(1-3):40-9. PubMed ID: 16820227
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activity of neural melanocortin receptors.
Tao YX; Huang H; Wang ZQ; Yang F; Williams JN; Nikiforovich GV
Methods Enzymol; 2010; 484():267-79. PubMed ID: 21036237
[TBL] [Abstract][Full Text] [Related]
10. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
11. Constitutive receptor activity series: endogenous inverse agonists and constitutive receptor activity in the melanocortin system.
Adan RA
Trends Pharmacol Sci; 2006 Apr; 27(4):183-6. PubMed ID: 16500715
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.
Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C
Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916
[TBL] [Abstract][Full Text] [Related]
13. Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.
Paisdzior S; Dimitriou IM; Schöpe PC; Annibale P; Scheerer P; Krude H; Lohse MJ; Biebermann H; Kühnen P
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059383
[TBL] [Abstract][Full Text] [Related]
14. Functions of transmembrane domain 3 of human melanocortin-4 receptor.
Mo XL; Yang R; Tao YX
J Mol Endocrinol; 2012 Dec; 49(3):221-35. PubMed ID: 23014838
[TBL] [Abstract][Full Text] [Related]
15. Biased signaling in fish melanocortin-4 receptors (MC4Rs): Divergent pharmacology of four ligands on spotted scat (Scatophagus argus) and grass carp (Ctenopharyngodon idella) MC4Rs.
Yang Z; Liang XF; Li GL; Tao YX
Mol Cell Endocrinol; 2020 Sep; 515():110929. PubMed ID: 32615281
[TBL] [Abstract][Full Text] [Related]
16. The MC4 receptor and control of appetite.
Adan RA; Tiesjema B; Hillebrand JJ; la Fleur SE; Kas MJ; de Krom M
Br J Pharmacol; 2006 Dec; 149(7):815-27. PubMed ID: 17043670
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of the constitutive activation of the L250Q human melanocortin-4 receptor polymorphism.
Proneth B; Xiang Z; Pogozheva ID; Litherland SA; Gorbatyuk OS; Shaw AM; Millard WJ; Mosberg HI; Haskell-Luevano C
Chem Biol Drug Des; 2006 Mar; 67(3):215-29. PubMed ID: 16611215
[TBL] [Abstract][Full Text] [Related]
18. Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.
Roubert P; Dubern B; Plas P; Lubrano-Berthelier C; Alihi R; Auger F; Deoliveira DB; Dong JZ; Basdevant A; Thurieau C; Clément K
J Endocrinol; 2010 Nov; 207(2):177-83. PubMed ID: 20696697
[TBL] [Abstract][Full Text] [Related]
19. Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor.
Kleinau G; Heyder NA; Tao YX; Scheerer P
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785054
[TBL] [Abstract][Full Text] [Related]
20. The natural inverse agonist agouti-related protein induces arrestin-mediated endocytosis of melanocortin-3 and -4 receptors.
Breit A; Wolff K; Kalwa H; Jarry H; Büch T; Gudermann T
J Biol Chem; 2006 Dec; 281(49):37447-56. PubMed ID: 17041250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
